Annual Current Ratio
10.68
+6.43+151.29%
31 December 2023
Summary:
Spyre Therapeutics annual current ratio is currently 10.68, with the most recent change of +6.43 (+151.29%) on 31 December 2023. During the last 3 years, it has risen by +5.77 (+117.52%). SYRE annual current ratio is now -36.24% below its all-time high of 16.75, reached on 01 December 2016.SYRE Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
7.32
-12.38-62.84%
30 September 2024
Summary:
Spyre Therapeutics quarterly current ratio is currently 7.32, with the most recent change of -12.38 (-62.84%) on 30 September 2024. Over the past year, it has dropped by -3.36 (-31.46%). SYRE quarterly current ratio is now -80.28% below its all-time high of 37.12, reached on 01 March 2015.SYRE Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -31.5% |
| 3 y3 years | +117.5% | +49.1% |
| 5 y5 years | +163.1% | +80.3% |
SYRE Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +151.3% | -62.8% | +610.7% |
| 5 y | 5 years | at high | +163.1% | -62.8% | +610.7% |
| alltime | all time | -36.2% | +313.9% | -80.3% | +610.7% |
Spyre Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 7.32(-62.8%) |
| June 2024 | - | 19.70(+73.1%) |
| Mar 2024 | - | 11.38(+6.6%) |
| Dec 2023 | 10.68(+151.3%) | 10.68(+132.7%) |
| Sept 2023 | - | 4.59(+345.6%) |
| June 2023 | - | 1.03(-70.7%) |
| Mar 2023 | - | 3.51(-17.4%) |
| Dec 2022 | 4.25(-13.4%) | - |
| Dec 2022 | - | 4.25(-8.6%) |
| Sept 2022 | - | 4.65(-23.6%) |
| June 2022 | - | 6.09(+36.9%) |
| Mar 2022 | - | 4.45(-9.4%) |
| Dec 2021 | 4.91(-46.1%) | 4.91(-14.6%) |
| Sept 2021 | - | 5.75(-11.8%) |
| June 2021 | - | 6.52(+39.3%) |
| Mar 2021 | - | 4.68(-48.6%) |
| Dec 2020 | 9.11(+124.4%) | 9.11(-9.4%) |
| Sept 2020 | - | 10.06(-1.3%) |
| June 2020 | - | 10.19(+221.5%) |
| Mar 2020 | - | 3.17(-21.9%) |
| Dec 2019 | 4.06 | 4.06(-32.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | 6.02(-28.7%) |
| June 2019 | - | 8.44(-21.4%) |
| Mar 2019 | - | 10.74(+43.4%) |
| Dec 2018 | 7.49(-23.3%) | 7.49(-20.1%) |
| Sept 2018 | - | 9.37(-26.7%) |
| June 2018 | - | 12.78(+50.9%) |
| Mar 2018 | - | 8.47(-13.3%) |
| Dec 2017 | 9.77(-41.7%) | 9.77(-19.9%) |
| Sept 2017 | - | 12.20(-18.6%) |
| June 2017 | - | 14.98(-1.7%) |
| Mar 2017 | - | 15.24(-9.0%) |
| Dec 2016 | 16.75(+10.4%) | 16.75(-10.3%) |
| Sept 2016 | - | 18.68(-18.4%) |
| June 2016 | - | 22.88(+148.2%) |
| Mar 2016 | - | 9.22(-39.2%) |
| Dec 2015 | 15.17(+488.0%) | 15.17(-12.1%) |
| Sept 2015 | - | 17.25(+2.7%) |
| June 2015 | - | 16.80(-54.7%) |
| Mar 2015 | - | 37.12(+1338.8%) |
| Dec 2014 | 2.58(-20.9%) | 2.58 |
| Dec 2013 | 3.26 | - |
FAQ
- What is Spyre Therapeutics annual current ratio?
- What is the all time high annual current ratio for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly current ratio year-on-year change?
What is Spyre Therapeutics annual current ratio?
The current annual current ratio of SYRE is 10.68
What is the all time high annual current ratio for Spyre Therapeutics?
Spyre Therapeutics all-time high annual current ratio is 16.75
What is Spyre Therapeutics quarterly current ratio?
The current quarterly current ratio of SYRE is 7.32
What is the all time high quarterly current ratio for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly current ratio is 37.12
What is Spyre Therapeutics quarterly current ratio year-on-year change?
Over the past year, SYRE quarterly current ratio has changed by -3.36 (-31.46%)